These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 28862956)

  • 1. Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis.
    Wei T; Huang G; Gao J; Huang C; Sun M; Wu J; Bu J; Shen W
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy.
    Yu W; Gao B; Li N; Wang J; Qiu C; Zhang G; Liu M; Zhang R; Li C; Ji G; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1973-1983. PubMed ID: 27794418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation.
    Zhang X; Ji R; Liao X; Castillero E; Kennel PJ; Brunjes DL; Franz M; Möbius-Winkler S; Drosatos K; George I; Chen EI; Colombo PC; Schulze PC
    Circulation; 2018 May; 137(19):2052-2067. PubMed ID: 29330215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT3 deficiency exacerbates p53/Parkin‑mediated mitophagy inhibition and promotes mitochondrial dysfunction: Implication for aged hearts.
    Li Y; Ma Y; Song L; Yu L; Zhang L; Zhang Y; Xing Y; Yin Y; Ma H
    Int J Mol Med; 2018 Jun; 41(6):3517-3526. PubMed ID: 29532856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice.
    Pillai VB; Bindu S; Sharp W; Fang YH; Kim G; Gupta M; Samant S; Gupta MP
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H962-72. PubMed ID: 26873966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin 3 deficiency aggravates angiotensin II-induced hypertensive cardiac injury by the impairment of lymphangiogenesis.
    Zhang C; Li N; Suo M; Zhang C; Liu J; Liu L; Qi Y; Zheng X; Xie L; Hu Y; Bu P
    J Cell Mol Med; 2021 Aug; 25(16):7760-7771. PubMed ID: 34180125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.
    Hafner AV; Dai J; Gomes AP; Xiao CY; Palmeira CM; Rosenzweig A; Sinclair DA
    Aging (Albany NY); 2010 Dec; 2(12):914-23. PubMed ID: 21212461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.
    Su H; Zeng H; Liu B; Chen JX
    J Cell Mol Med; 2020 Jul; 24(14):8057-8068. PubMed ID: 32463172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT3 (Sirtuin-3) Prevents Ang II (Angiotensin II)-Induced Macrophage Metabolic Switch Improving Perivascular Adipose Tissue Function.
    Wei (魏彤) T; Gao (高晶) J; Huang (黄程淋) C; Song (宋蓓) B; Sun (孙孟炜) M; Shen (沈伟利) W
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):714-730. PubMed ID: 33327751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT3 Ablation Deteriorates Obesity-Related Cardiac Remodeling by Modulating ROS-NF-κB-MCP-1 Signaling Pathway.
    Guo X; Yan F; Li J; Zhang C; Su H; Bu P
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):296-304. PubMed ID: 32898015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaredoxin-2 and Sirtuin-3 deficiencies impair cardiac mitochondrial energetics but their effects are not additive.
    Boardman NT; Migally B; Pileggi C; Parmar GS; Xuan JY; Menzies K; Harper ME
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165982. PubMed ID: 33002579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
    He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
    J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Deacetylase Sirt3 Reduces Vascular Dysfunction and Hypertension While Sirt3 Depletion in Essential Hypertension Is Linked to Vascular Inflammation and Oxidative Stress.
    Dikalova AE; Pandey A; Xiao L; Arslanbaeva L; Sidorova T; Lopez MG; Billings FT; Verdin E; Auwerx J; Harrison DG; Dikalov SI
    Circ Res; 2020 Feb; 126(4):439-452. PubMed ID: 31852393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdependence of Parkin-Mediated Mitophagy and Mitochondrial Fission in Adult Mouse Hearts.
    Song M; Gong G; Burelle Y; Gustafsson ÅB; Kitsis RN; Matkovich SJ; Dorn GW
    Circ Res; 2015 Jul; 117(4):346-51. PubMed ID: 26038571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes.
    Wang C; Yang Y; Zhang Y; Liu J; Yao Z; Zhang C
    Biosci Trends; 2019 Jan; 12(6):605-612. PubMed ID: 30584213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.
    Qiao A; Wang K; Yuan Y; Guan Y; Ren X; Li L; Chen X; Li F; Chen AF; Zhou J; Yang JM; Cheng Y
    Oncotarget; 2016 Jul; 7(28):43390-43400. PubMed ID: 27270321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.
    Bouabout G; Ayme-Dietrich E; Jacob H; Champy MF; Birling MC; Pavlovic G; Madeira L; Fertak LE; Petit-Demoulière B; Sorg T; Herault Y; Mudgett J; Monassier L
    Arch Cardiovasc Dis; 2018 Jan; 111(1):41-52. PubMed ID: 29113787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Endothelial-to-Mesenchymal Transition by SIRT (Sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury.
    Lin JR; Zheng YJ; Zhang ZB; Shen WL; Li XD; Wei T; Ruan CC; Chen XH; Zhu DL; Gao PJ
    Hypertension; 2018 Aug; 72(2):350-360. PubMed ID: 29915018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension.
    Dikalova AE; Itani HA; Nazarewicz RR; McMaster WG; Flynn CR; Uzhachenko R; Fessel JP; Gamboa JL; Harrison DG; Dikalov SI
    Circ Res; 2017 Aug; 121(5):564-574. PubMed ID: 28684630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.